Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Julia Musto

New fleet of weight loss drugs are more effective than the current popular obesity medications at trial

Eli Lilly and Company announced in December that its next-generation weight loss drug retatrutide helped patients shed more pounds than any other similar weight-loss drug during a late-stage trial.

Patients taking the once-weekly drug over the course of 68 weeks lost nearly 29 percent of their body weight, whereas patients taking semaglutide drugs such as Ozempic or Wegovy previously lost only 16 percent.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.